Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
To compare versus placebo the efficacy and safety of recombinant Bet v1, natural purified Bet v1 and birch pollen licenced extract used for subcutaneous immunotherapy.
Epistemonikos ID: 7f42d26aa1f27f66bc21d2eb27a774591c4cb3b1
First added on: May 04, 2024